Saturday, March 21, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Innovations & Investing

Cyber Risk Is Now a Core Procurement Metric — Expanded Analysis

Cybersecurity risk in healthcare has shifted from a technical concern to a core operational and procurement variable

DAILY REMEDY by DAILY REMEDY
February 4, 2026
in Innovations & Investing
0

Cybersecurity risk in healthcare has shifted from a technical concern to a core operational and procurement variable. Health system leaders increasingly treat cyber disruption not as a low-probability event but as a modeled operational scenario. This shift is changing how technology vendors are evaluated, how architectures are designed, and how purchasing decisions are scored. Cyber resilience is now assessed alongside clinical functionality and financial return.

Healthcare cybersecurity incidents are no longer rare shocks. Ransomware events, vendor compromises, credential breaches, and data integrity attacks occur with sufficient frequency that executive teams plan for them explicitly. Scenario modeling is replacing assumption-based prevention. Boards and executive committees increasingly ask not only how breaches are prevented, but how operations continue when prevention fails.

Scenario planning is replacing checklist security as the dominant evaluation model. Traditional vendor security reviews emphasized control checklists: encryption standards, access controls, and compliance certifications. Current reviews increasingly include scenario exercises. Vendors may be asked how their systems behave under network isolation, credential compromise, or upstream vendor breach. Behavior under stress is evaluated alongside preventive controls.

Downtime tolerance is being quantified at the system level. Committees define maximum tolerable downtime for different categories of technology: mission-critical clinical systems, operational support systems, and analytic tools. Vendors are required to map their products to these tolerance tiers. Higher-tier systems face stricter resilience and recovery expectations. Availability is graded rather than assumed.

Architectural resilience features are gaining weight in procurement scoring. Offline modes, read-only fallbacks, local caching, and rapid restore capabilities are evaluated explicitly. Redundancy design is discussed in vendor reviews. Systems that degrade gracefully receive higher resilience scores than systems that fail completely. Recovery posture is now considered part of security posture.

Supply chain exposure has become visible at the executive level. Software supply chain risk includes third-party libraries, cloud service dependencies, and subcontracted development components. Vendor dependency mapping is increasingly requested. Organizations want to understand concentration risk — whether multiple critical systems depend on the same upstream provider. Opaque dependency stacks trigger extended review.

Transparency reduces perceived fragility. Vendors that provide software bills of materials, dependency disclosures, and patch cadence documentation move through review processes more quickly. Disclosure discipline is becoming a competitive differentiator. Security maturity is partly measured by reporting transparency.

Cyber insurance is shaping architecture decisions. Insurance carriers increasingly impose technical control requirements as coverage conditions. Logging standards, segmentation requirements, backup practices, and authentication controls may be mandated by underwriting criteria. Vendors must align product design with insured control frameworks. Insurance requirements become design constraints.

Procurement processes now integrate cybersecurity review earlier in evaluation. Security review is no longer a late-stage checkpoint after functional approval. In many organizations, vendors cannot advance without preliminary security clearance. This parallel evaluation model lengthens early review but reduces late-stage rejection risk.

Second-order effects are visible in product development velocity. Security-driven architecture can slow feature release cycles because additional controls, testing, and validation are required. However, slower release cadence may improve adoption probability because risk tolerance is low among buyers. The safest tool may ship slower but sell faster. Risk tolerance shapes technical priorities.

Vendor incident response capability is now evaluated as a product attribute. Procurement teams examine breach notification timelines, customer communication protocols, and incident support structures. Response choreography is assessed alongside detection capability. Institutions want evidence that vendors can coordinate effectively during crisis events.

For clinicians, the operational implication is that cyber resilience affects clinical continuity. Technology selection influences downtime frequency and recovery speed. Systems chosen for resilience reduce clinical disruption during incidents. Cybersecurity is therefore indirectly a patient safety factor.

For physician leaders, participation in procurement discussions increasingly includes resilience considerations. Clinical leaders may be asked to define acceptable downtime thresholds and workflow fallback requirements. Clinical input shapes resilience scoring because clinical tolerance varies by function.

Cyber risk has moved from the information technology department to the executive and board level. Procurement frameworks now treat cyber resilience as a primary evaluation dimension. Technology architecture is being shaped by modeled disruption scenarios rather than only by feature roadmaps.

Cybersecurity is no longer only about breach prevention. It is about operational continuity under breach conditions. Procurement decisions reflect this broader framing. Cyber risk is now a standing procurement variable, not an episodic concern.

ShareTweet
DAILY REMEDY

DAILY REMEDY

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

This episode explores deceptive pricing strategies in the GLP-1 medication market, highlighting how healthcare consumerism influences patient decisions and how to recognize and protect against misleading practices.

 key  topics

Deceptive pricing strategies in healthcare
The role of brand perception and pricing manipulation
The concept of drip pricing and hidden costs
The rise of healthcare consumerism and patient agency
Strategies for patients to identify and avoid deceptive practices

Chapters

00:00 The Evolution of the GLP-1 Telemedicine Market
01:12 How Pricing Is Obscured and Perceived Discounts Are Created
02:11 TrumpRx: Coupon Aggregator or Discount Store?
03:12 Why Price Deception Thrives in Healthcare
04:12 The Membership Fee Illusion and Hidden Costs
05:10 Brand Recognition and Drip Pricing Strategies
06:17 The Impact of Brand and Anchor Pricing on Perceived Value
07:16 The Role of Price Drip Strategies in Healthcare Pricing
08:15 The Rise of Healthcare Consumerism and Patient Agency
09:14 How to Protect Yourself from Deceptive Pricing Practices
10:09 Conclusion: Empowering Patients in a Complex Pricing Landscape
Unmasking Deceptive Pricing in Healthcare: What Patients Need to Know
YouTube Video zZgo1nLZVrY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • A Call to Action for Pain Patients and Advocates

    A Call to Action for Pain Patients and Advocates

    1 shares
    Share 0 Tweet 0
  • The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    0 shares
    Share 0 Tweet 0
  • Retatrutide and the Acceleration of Metabolic Medicine

    0 shares
    Share 0 Tweet 0
  • Healthcare’s Logistics Push

    0 shares
    Share 0 Tweet 0
  • Curious Case of Rising Death Rates

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy